Taking everything into account, HALO scores 8 out of 10 in our fundamental rating. HALO was compared to 568 industry peers in the Biotechnology industry. HALO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HALO is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, HALO could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year HALO was profitable.
HALO had a positive operating cash flow in the past year.
In the past 5 years HALO has always been profitable.
Each year in the past 5 years HALO had a positive operating cash flow.
1.2 Ratios
The Return On Assets of HALO (21.52%) is better than 98.94% of its industry peers.
HALO's Return On Equity of 122.06% is amongst the best of the industry. HALO outperforms 99.47% of its industry peers.
The Return On Invested Capital of HALO (23.00%) is better than 99.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HALO is above the industry average of 14.25%.
The 3 year average ROIC (17.81%) for HALO is below the current ROIC(23.00%), indicating increased profibility in the last year.
Industry Rank
Sector Rank
ROA
21.52%
ROE
122.06%
ROIC
23%
ROA(3y)16.25%
ROA(5y)21.49%
ROE(3y)192.36%
ROE(5y)173.4%
ROIC(3y)17.81%
ROIC(5y)29.79%
1.3 Margins
HALO has a better Profit Margin (43.74%) than 99.12% of its industry peers.
In the last couple of years the Profit Margin of HALO has declined.
The Operating Margin of HALO (54.32%) is better than 99.82% of its industry peers.
HALO's Operating Margin has declined in the last couple of years.
HALO's Gross Margin of 84.30% is amongst the best of the industry. HALO outperforms 86.97% of its industry peers.
In the last couple of years the Gross Margin of HALO has grown nicely.